303 related articles for article (PubMed ID: 35956335)
1. Probiotics Administration in Cystic Fibrosis: What Is the Evidence?
Esposito S; Testa I; Mariotti Zani E; Cunico D; Torelli L; Grandinetti R; Fainardi V; Pisi G; Principi N
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956335
[TBL] [Abstract][Full Text] [Related]
2. Probiotic supplementation in children with cystic fibrosis-a systematic review.
Ananthan A; Balasubramanian H; Rao S; Patole S
Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
[TBL] [Abstract][Full Text] [Related]
3. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.
Madan JC
Clin Ther; 2016 Apr; 38(4):740-6. PubMed ID: 26973296
[TBL] [Abstract][Full Text] [Related]
4. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
5. Probiotics for people with cystic fibrosis.
Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
[TBL] [Abstract][Full Text] [Related]
6. An
Barrack KE; Hampton TH; Valls RA; Surve SV; Gardner TB; Sanville JL; Madan JL; O'Toole GA
J Bacteriol; 2024 Jan; 206(1):e0028623. PubMed ID: 38169295
[TBL] [Abstract][Full Text] [Related]
7. A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.
Vernocchi P; Del Chierico F; Quagliariello A; Ercolini D; Lucidi V; Putignani L
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29232848
[TBL] [Abstract][Full Text] [Related]
8. What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?
van Dorst JM; Tam RY; Ooi CY
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276841
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
10. Probiotic use in adults with cystic fibrosis is common and influenced by gastrointestinal health needs: A cross-sectional survey study.
Anderson JL; Tierney AC; Miles C; Kotsimbos T; King SJ
J Hum Nutr Diet; 2022 Jun; 35(3):444-454. PubMed ID: 35092114
[TBL] [Abstract][Full Text] [Related]
11. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis.
Nielsen S; Needham B; Leach ST; Day AS; Jaffe A; Thomas T; Ooi CY
Sci Rep; 2016 May; 6():24857. PubMed ID: 27143104
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome a promising target for management of respiratory diseases.
Trivedi R; Barve K
Biochem J; 2020 Jul; 477(14):2679-2696. PubMed ID: 32726437
[TBL] [Abstract][Full Text] [Related]
13. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures.
Madan JC; Koestler DC; Stanton BA; Davidson L; Moulton LA; Housman ML; Moore JH; Guill MF; Morrison HG; Sogin ML; Hampton TH; Karagas MR; Palumbo PE; Foster JA; Hibberd PL; O'Toole GA
mBio; 2012; 3(4):. PubMed ID: 22911969
[TBL] [Abstract][Full Text] [Related]
14. The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.
Garg M; Ooi CY
Curr Gastroenterol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155088
[TBL] [Abstract][Full Text] [Related]
15. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis.
Karb DB; Cummings LC
Curr Gastroenterol Rep; 2021 Aug; 23(10):17. PubMed ID: 34448955
[TBL] [Abstract][Full Text] [Related]
16. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
[TBL] [Abstract][Full Text] [Related]
17. Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis.
Thavamani A; Salem I; Sferra TJ; Sankararaman S
Metabolites; 2021 Feb; 11(2):. PubMed ID: 33671639
[TBL] [Abstract][Full Text] [Related]
18. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis.
Marsh R; Gavillet H; Hanson L; Ng C; Mitchell-Whyte M; Major G; Smyth AR; Rivett D; van der Gast C
J Cyst Fibros; 2022 May; 21(3):506-513. PubMed ID: 34895838
[TBL] [Abstract][Full Text] [Related]
19. Probiotics and Covid-19.
Bottari B; Castellone V; Neviani E
Int J Food Sci Nutr; 2021 May; 72(3):293-299. PubMed ID: 32787470
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the colorectal microbiome in adult cystic fibrosis patients.
Gilbert B; Kaiko G; Smith S; Wark P
Colorectal Dis; 2023 May; 25(5):843-852. PubMed ID: 36598333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
